Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Study Phase
Phase 3
Study Completion Date
December 2022
NCT02883049Uploaded 04-27-2021
Access via NCI by Request
PDS UID: nci-data-466
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Files: NCT02883049-D1
Data DictionaryNCT02883049-D1-Data-Dictionary_2.pdf
Files: NCT02883049-D2
Data DictionaryNCT02883049-D2-Data-Dictionary_3.pdf
Files: NCT02883049-D3
Data DictionaryNCT02883049-D3-Data-Dictionary_2.pdf